New patent for Astrazeneca Ab drug BYDUREON BCISE

Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are sixteen…

The post New patent for Astrazeneca Ab drug BYDUREON BCISE appeared first on DrugPatentWatch.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: